There appears to be no increased risk for serious cardiovascular events associated with stimulant medication use by children and adolescents with autism spectrum disorder (ASD), according to new research. In an analysis of more than 300,000 ASD patients, the incidence rate of serious cardiac events was approximately 0.01%, a rate that was statistically comparable for ASD patients who were taking stimulant medications and their counterparts who were not taking such medications.